Nicotine Mini Lozenge
Product Images NDC 46122-731

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Nicotine Mini (NDC 46122-731). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amerisourcebergen (good Neighbor Pharmacy) 46122, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Nicotine Polacrilex 2 mg (Nicotine 2 mg Mint Mini Lozenge Pld Miami 1)

Nicotine Polacrilex 2 mg (Nicotine 2 mg Mint Mini Lozenge Pld Miami 1)
Drug Facts label for Nicotine Mini Lozenge 2 mg by AmerisourceBergen, outlining active ingredient nicotine polacrilex 2 mg, usage to reduce withdrawal symptoms from quitting smoking, warnings, directions including a 12-week schedule, and other information such as storage and inactive ingredients. The label also emphasizes age restrictions, safety warnings, and contact information for questions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.